KyDo Therapeutics
PrivateLast Round
Grant
Jan 1, 2026
Total Funding Raised
$4.81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KyDo Therapeutics Comparables
Compare KyDo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adoram Therapeutics | 85% | |
| Antares Therapeutics | 82% | |
| Hyku Biosciences | 80% | |
KyDo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2026 | ||||
| Seed | Sep 16, 2025 |
KyDo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TU capital | Seed |
| KHAN Technology Transfer Fund II | Seed |
| VORNvc | Seed |
| State of North Rhine-Westphalia | Grant |
| i&i Prague | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Received funding from the European Union and the State of North Rhine-Westphalia.
- Sep 16, 2025
$5.28M round led by i&i Biotech Fund I
KyDo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KyDo Therapeutics's valuation, stock price, and market status.